Expression data from skin biopsies in patients with systemic sclerosis treated with beta-catenin inhibitor (C82) and placebo

ABSTRACT: Wnt signaling pathway is thought to have a role in skin fibrosis in Systemic slcerosis. This Randomized, Placebo-Controlled trial examines the effect of beta catenin inhibition on skin expression. We used microarrays to explore gene expression changes in the C82 trial

ORGANISM(S): Homo sapiens

PROVIDER: GSE94340 | GEO | 2018/01/01

SECONDARY ACCESSION(S): PRJNA369403

REPOSITORIES: GEO